# US 2025/0155439 A1 · Ligand Operable Protein Cages

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0155439 A1
- Document ID: US20250155439A1
- Status: Published application
- Kind: A1
- Application number: 18/834,817
- Filed: 2023-02-08
- Published: 2025-05-15
- Earliest claimed: 2022-02-09
- Assignees: The Regents of the University of California
- Applicants: The Regents of the University of California
- Inventors: Todd Owen Yeates; Justin Miller; Eric Jinsuk Lee
- Web page: https://patentgrep.com/patent/US20250155439A1

## CPC

- G01N 33/573: for enzymes or isoenzymes
- C07K 14/001: {by chemical synthesis}
- C12N 9/0069: {acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)}
- C12Y 113/11055: Sulfur oxygenase/reductase (1.13.11.55)
- G01N 33/542: with steric inhibition or signal modification, e.g. fluorescent quenching
- C07K 2318/20: Antigen-binding scaffold molecules wherein the scaffold is not an immunoglobulin variable region or antibody mimetics
- C07K 2319/00: Fusion polypeptide
- G01N 2333/90241: acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

Disclosed herein are protein cages that can be assembled and disassembled on command and methods and compositions thereof.

## Claims

### Claim 1

A ligand operable protein cage (LOC), which comprises a plurality of subunits bound together by non-covalent interactions, wherein at least one subunit comprises a sequence that has (a) at least 90% sequence identity over a comparison window of at least X-30 consecutive amino acid residues of a subunit protein having X number of amino acid residues, said subunit protein being of a known protein cage, and (b) a given binder covalently attached to the N-terminus or the C-terminus of the at least one subunit.

### Claim 2 (depends on 1)

The LOC according to claim 1, wherein the known protein cage is selected from the group consisting of T33-51, T33-31, T33-21, T33-28, I53-40, I52-32, I32-28, ferritin, and sulfur oxygenase reductase.

### Claim 3 (depends on 1)

The LOC according to claim 1, wherein the sequence of the subunit protein is selected from the group consisting of SEQ ID NOs: 1-20 and SEQ ID NOs: 38-56.

### Claim 4 (depends on 1)

The LOC according to claim 1, wherein the sequence of the subunit protein is SEQ ID NO: 2 or SEQ ID NO: 34.

### Claim 5 (depends on 1)

The LOC according to claim 1, wherein the given binder is an scFv, a Fab fragment, a Fab′ fragment, a F(ab′)2 fragment, an sdFv, an Fv, a protein comprising a set of CDRs of an antibody, a camelid nanobody, an affibody, an affilin, an affimer, an affitin, an alphabody, an anticalin, an avimer, a DARPin, an Fynomer, a Kunitz domain peptide, a monobody, or a nanoCLAMP known in the art.

### Claim 6 (depends on 1)

The LOC according to claim 1, wherein the given binder is a DARPin or an affibody.

### Claim 7 (depends on 6)

The LOC according to claim 6, wherein the DARPin comprises SEQ ID NO: 21.

### Claim 8 (depends on 6)

The LOC according to claim 6, wherein the affibody comprises SEQ ID NO: 29.

### Claim 9 (depends on 1)

The LOC according to claim 1, wherein the non-covalent interactions between the subunit and one of its adjacent subunits are disrupted when the given binder has its cognate ligand bound thereto.

### Claim 10 (depends on 1)

The LOC according to claim 1, and further comprising a passenger molecule of interest covalently attached to the at least one subunit.

### Claim 11 (depends on 1)

The LOC according to claim 1, wherein a passively packaged passenger molecule of interest is in the interior cavity of the LOC.

### Claim 12 (depends on 10)

The LOC according to claim 10, wherein the passenger molecule and/or the passively packaged passenger molecule is a detectable label, a detection reagent, a theradiagnostic of interest, or a radiotheranostic of interest.

### Claim 13 (depends on 11)

A method of delivering or releasing the passenger molecule claim 11, which comprises contacting the given binder with its cognate ligand.

### Claim 14 (depends on 1)

An assay method which comprises using the LOC according to claim 1 to detect the presence or absence of the cognate ligand of the given binder in a sample by contacting the LOC with the sample and detecting the presence of absence of the cognate ligand bound to the given binder, wherein disassembly of the at least one subunit from the plurality of subunits indicates the presence of the cognate ligand.

### Claim 15 (depends on 1)

A composition which comprises one or more LOCs according to claim 1.

### Claim 16 (depends on 1)

A kit which comprises one or more LOCs according to claim 1 packaged together with the cognate ligand of the given binder and/or a reagent for detecting the disassembly of the at least one subunit from the plurality of subunits.
